Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Is Low Dose Combination Therapy Effective for Migraine Prophylaxis ? A Case Series Study

Sina Karamimagham 1 , Tahereh Poursadeghfard 2 and Maryam Poursadeghfard 3 , *
Authors Information
1 Department of Pediatrics, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
2 Department of Statistics, Islamic Azad University, Firooz Abad Branch, Fars, Iran
3 Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: October 2016, 18 (10); e3804
  • Published Online: October 8, 2016
  • Article Type: Research Article
  • Received: August 9, 2015
  • Revised: November 8, 2015
  • Accepted: September 24, 2016
  • DOI: 10.17795/zjrms-3804

To Cite: Karamimagham S, Poursadeghfard T, Poursadeghfard M. Is Low Dose Combination Therapy Effective for Migraine Prophylaxis ? A Case Series Study, Zahedan J Res Med Sci. 2016 ; 18(10):e3804. doi: 10.17795/zjrms-3804.

Abstract
Copyright © 2016, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Methods and Patients
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Silberstein SD, Dodick D, Freitag F, Pearlman SH, Hahn SR, Scher AI, et al. Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapy. Headache. 2007; 47(4): 585-99[DOI][PubMed]
  • 2. Pascual J. Recent advances in the pharmacological management of migraine. F1000 Med Rep. 2009; 1(39)
  • 3. Kelman L. Migraine changes with age: IMPACT on migraine classification. Headache. 2006; 46(7): 1161-71[DOI][PubMed]
  • 4. Bahrami P, Zebardast H, Zibaei M, Mohammadzadeh M, Zabandan N. Prevalence and characteristics of headache in Khoramabad, Iran. Pain Physician. 2012; 15(4): 327-32[PubMed]
  • 5. Holroyd KA, Cottrell CK, O'Donnell FJ, Cordingley GE, Drew JB, Carlson BW, et al. Effect of preventive (  blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. Bmj. 2010; 341: 4871[DOI]
  • 6. Zencirci B. Comparison of the effects of dietary factors in the management and prophylaxis of migraine. J Pain Res. 2010; 3: 125-30[PubMed]
  • 7. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007; 68(5): 343-9[DOI][PubMed]
  • 8. Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, et al. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2007; 6(12): 1054-62[DOI][PubMed]
  • 9. Pascual J, El Berdei Y, Gomez-Sanchez JC. How many migraine patients need prolonged (>1 year) preventive treatment? Experience with topiramate. J Headache Pain. 2007; 8(2): 90-3[DOI][PubMed]
  • 10. Pompili M, Serafini G, Innamorati M, Serra G, Dominici G, Fortes-Lindau J, et al. Patient outcome in migraine prophylaxis: the role of psychopharmacological agents. Patient Relat Outcome Meas. 2010; 1: 107-18[DOI][PubMed]
  • 11. Modi S, Lowder DM. Medications for migraine prophylaxis. Am Fam Physician. 2006; 73(1): 72-8[PubMed]
  • 12. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, et al. EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol. 2006; 13(6): 560-72[DOI][PubMed]
  • 13. Krymchantowski AV, da Cunha Jevoux C, Bigal ME. Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders. J Headache Pain. 2012; 13(1): 53-9[DOI][PubMed]
  • 14. Headache Classification Subcommittee of the International Headache Society. 2004; 24: 8-160
  • 15. Pain Rating Scale. The British Pain Society [internet]. Charity no. 1103260. 2006;
  • 16. Boes CJ, Capobianco DJ, Cutrer FM, Dodick DW, Garza I, Swanson JW. Headache and other craniofacial pain. In: Bradley WJ, Daroff RB, Fenichel GM, Jankovic J, eds. Neurology in clinical practice. 2008; : 2037-8
  • 17. Gobel H. Botulinum toxin in migraine prophylaxis. J Neurol. 2004; 251 Suppl 1-11[DOI][PubMed]
  • 18. Sullivan E, Bushnell C. Management of menstrual migraine: a review of current abortive and prophylactic therapies. Curr Pain Headache Rep. 2010; 14(5): 376-84[DOI][PubMed]
  • 19. Dekker F, Knuistingh Neven A, Andriesse B, Kernick D, Reis R, Ferrari MD, et al. Prophylactic treatment of migraine; the patient's view, a qualitative study. BMC Fam Pract. 2012; 13: 13[DOI][PubMed]
  • 20. Loj J, Solomon GD. Migraine prophylaxis: who, why, and how. Cleve Clin J Med. 2006; 73(9): 793-4-800-1 passim[PubMed]
  • 21. Cady R, Schreiber C. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Headache. 2008; 48(6): 900-13[DOI][PubMed]
  • 22. Pringsheim T, Davenport WJ, Becker WJ. Prophylaxis of migraine headache. CMAJ. 2010; 182(7): 269-76[DOI][PubMed]
  • 23. Kol CM, Dekker F, Neven AK, Assendelft WJ, Blom JW. Acceptance or rejection of prophylactic medicine in patients with migraine: a cross-sectional study. Br J Gen Pract. 2008; 58(547): 98-101[DOI][PubMed]
  • 24. Garza I, Swanson JW. Prophylaxis of migraine. Neuropsychiatr Dis Treat. 2006; 2(3): 281-91[PubMed]
  • 25. Domingues RB, Silva AL, Domingues SA, Aquino CC, Kuster GW. A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine. Arq Neuropsiquiatr. 2009; 67(4): 973-7[PubMed]
  • 26. Bigal ME, Krymchantowski AV. Emerging drugs for migraine prophylaxis and treatment. MedGenMed. 2006; 8(2): 31[PubMed]
  • 27. Dib M. Optimizing prophylactic treatment of migraine: Subtypes and patient matching. Ther Clin Risk Manag. 2008; 4(5): 1061-78[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments